1. Home
  2. THFF vs CERT Comparison

THFF vs CERT Comparison

Compare THFF & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Financial Corporation Indiana

THFF

First Financial Corporation Indiana

HOLD

Current Price

$68.01

Market Cap

796.4M

Sector

Finance

ML Signal

HOLD

CERT

Certara Inc.

HOLD

Current Price

$6.33

Market Cap

860.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
THFF
CERT
Founded
1984
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Retail: Computer Software & Peripheral Equipment
Sector
Finance
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
796.4M
860.9M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
THFF
CERT
Price
$68.01
$6.33
Analyst Decision
Hold
Buy
Analyst Count
2
10
Target Price
$62.00
$11.67
AVG Volume (30 Days)
59.7K
2.5M
Earning Date
04-28-2026
05-11-2026
Dividend Yield
3.46%
N/A
EPS Growth
67.00
87.50
EPS
1.67
N/A
Revenue
N/A
$418,838,000.00
Revenue This Year
$17.88
$4.18
Revenue Next Year
$4.03
$5.39
P/E Ratio
$40.49
N/A
Revenue Growth
N/A
8.75
52 Week Low
$49.70
$5.19
52 Week High
$69.21
$13.88

Technical Indicators

Market Signals
Indicator
THFF
CERT
Relative Strength Index (RSI) 60.59 55.41
Support Level $64.41 $5.93
Resistance Level $68.96 $6.48
Average True Range (ATR) 1.70 0.28
MACD 0.06 0.04
Stochastic Oscillator 87.50 76.87

Price Performance

Historical Comparison
THFF
CERT

About THFF First Financial Corporation Indiana

First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities.

About CERT Certara Inc.

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.

Share on Social Networks: